We are monitoring the impact of COVID-19 on RIA Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 3555
Share on
Share on

Global Radioimmunoassay Market Size, Share, Trends, Growth Analysis Report – Segmented By Type, End-User, Application & Region – Industry Forecast (2020 to 2025)

Pulished: February, 2020
ID: 3555
Pages: 175

RIA Market Size (2020 to 2025)

The global radioimmunoassay market size is forecasted to grow USD 470.01 million by 2025 from USD 395.43 million in 2020, growing at a CAGR of 3.52% between 2020 to 2025.

Radioimmunoassay is a process used to measure specific proteins or any other substances through agents or antibodies.

Radioimmunoassay is essential in the medical field attributed to high quality, correct, relating individual results, and sensitivity. Radioimmunoassay analyzer is a device that helps to run the tests to examine the existence and focus on the substances in the samples present. Radioimmunoassay includes three levels of factors like a pure antigen, radiolabeled antigen, and an antibody. Advance technologies in the process of clinical trials in a test tube and growing demand for correct and quality results and need for more reagents and their kits are increasing the market.

MARKET DRIVERS:

The rising prevalence of infectious diseases and growing cancer cases throughout the world are principally driving the global radioimmunoassay market growth. Coronavirus, malaria, HIV/AIDS, and influenza are some of the most common infectious diseases. Worldwide, countries like Brazil, the United States, EU5, and China had the majority of the population diagnosed with infectious diseases in 2019. As per the World Health Organization, cancer is the 2nd most dangerous disease giving more deaths, and there were around 9.8 million deaths occurred due to cancer in 2018.

The rise in the concern towards health and diagnosing various infections in the human body is driving the market growth. Further, the market's development is increasing the number of blood donation camps and the need to determine infections in the blood. Stringent rules and regulations by the government regarding people's health safety are to set up growth opportunities for the radioimmunoassay market.

Increasing awareness overutilization of this technique in various applications and rise in the demand for point of care testing are also fueling the growth of the market.

MARKET RESTRAINTS:

However, the lack of skilled personnel in monitoring the systems and understanding the reports is degrading market demand. The cost of installing and maintaining the devices is a little high, and this attribute impedes the growth of the market.

REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2019 to 2025

Base Year

2019

Forecast Period

2020 to 2025

Segments Analysed

By Type, End-User, Application, and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter's Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Analysed

North America, Europe, Asia Pacific, Latin America, Middle East and Africa

 

This research report on the global radioimmunoassay market has been segmented and sub-segmented based on type, end-user, application, and region.

Radioimmunoassay Market – By Type:

  • Reagents and Kits               
  • Analyzers 

Based on type, the reagents and kits segment leads with the highest shares of the RIA market. Increasing support from the government through investments is boosting up the demand of the market extensively.

Radioimmunoassay Market – By End User

  • Hospitals
  • Pharmaceutical Industry and CRO 
  • Clinical Diagnostic Laboratories       

Based on the end-user, the hospital's category dominates with the highest shares of the RIA market. The rise in the constructional activities of hospitals with the latest equipment is escalating the demand of the market.

Radioimmunoassay Market – By Application:

  • Research 
  • Clinical Diagnostics

Based on the application, the clinical diagnostic application dominates the most significant shares of the RIA market. The rise in the scale of pharmaceutical companies is leveling up the growth of the market.

Radioimmunoassay Market – By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

North America is leading dominant shares of the global RIA market. Increasing demand for early diagnosis procedures is gearing up the need of the market to the extent. Europe is following North America in holding the most significant shares of the market. The growing number of campaigns, especially in rural areas, and the rise in the scale of blood banks are gearing up the market demand.

Asia pacific is to have the highest growth rate in the coming years with the adoption of advanced technologies and also the launch of various products. The Middle East and Africa are esteemed to have slight variations in the growth rate shortly.

KEY MARKET PLAYERS:

Companies dominating the global radioimmunoassay market profiled in the report are DIAsource Immunoassays SA, Beckman Coulter, IBL International, PerkinElmer, DRG International, MP Biomedicals LLC, Cisbio, Euro Diagnostica AB, DiaSorin S.p.A, EMD Millipore, Izotop, Berthold Technologies GmbH & Co. KG and Stratec Biomedical AG.

1. Introduction                                 

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Type                              

                                5.1.1 Introduction           

                                5.1.2 Reagents and Kits                

                                5.1.3 Analyzers 

                                5.1.4  Y-o-Y Growth Analysis, By Type    

                                5.1.5  Market Attractiveness Analysis, By Type  

                                5.1.6  Market Share Analysis, By Type    

                5.2 End User                      

                                5.2.1 Introduction           

                                5.2.2 Hospital    

                                5.2.3 Pharmaceutical Industry and CRO 

                                5.2.4 Clinical Diagnostic Laboratories       

                                5.2.5 Y-o-Y Growth Analysis, By End User             

                                5.2.6 Market Attractiveness Analysis, By End User           

                                5.2.7 Market Share Analysis, By End User             

                5.3 Application                 

                                5.3.1 Introduction           

                                5.3.2 Research  

                                5.3.3 Clinical Diagnostics               

                                5.3.4 Y-o-Y Growth Analysis, By Application         

                                5.3.5  Market Attractiveness Analysis, By Application      

                                5.3.6  Market Share Analysis, By Application       

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Type

                                                6.1.3.3 By End User

                                                6.1.3.4 By Application

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Type

                                                6.1.4.3 By End User

                                                6.1.4.4 By Application

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Type

                                                6.1.5.3 By End User

                                                6.1.5.4 By Application

                6.2 North America                          

                                6.1.1 Introduction           

                                6.1.2 United States         

                                6.1.3 Canada     

                6.3 Europe                         

                                6.2.1 Introduction           

                                6.2.2 U.K             

                                6.2.3 Spain         

                                6.2.4 Germany 

                                6.2.5 Italy            

                                6.2.6 France       

                6.4 Asia-Pacific                 

                                6.3.1 Introduction           

                                6.3.2 China         

                                6.3.3 India          

                                6.3.4 Japan         

                                6.3.5 Australia   

                                6.3.6 South Korea           

                6.5 Latin America                             

                                6.4.1 Introduction           

                                6.4.2 Brazil          

                                6.4.3 Argentina

                                6.4.4 Mexico     

                                6.4.5 Rest of Latin America          

                6.6 Middle East & Africa                               

                                6.5.1 Introduction           

                                6.5.2 Middle-East            

                                6.5.3 Africa         

7. Strategic Analysis                                       

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis                                        

                8.1 DIAsource ImmunoAssays SA                             

                                8.1.1 Overview 

                                8.1.2 Type Analysis         

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Beckman Coulter                     

                8.3 IBL International                       

                8.4 PerkinElmer                               

                8.5 DRG international                    

                8.6 MP Biomedicals                        

                8.7 Cisbio                            

                8.8 Euro Diagnostica AB                

                8.9 DiaSorin                       

                8.10 Stratec Biomedical                

9. Competitive Landscape                                           

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10. Market Outlook and Investment Opportunities                                         

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Global Radioimmunoassay Market, By Region, From 2020 to 2025 (USD Million)
  2. Global Radioimmunoassay Market, By Type, From 2020 to 2025 (USD Million)
  3. Global Reagents and Kits Market, By Region, From 2020 to 2025 (USD Million)
  4. Global Analyzers Market, By Region, From 2020 to 2025 (USD Million)
  5. Global Radioimmunoassay Market, By End User, From 2020 to 2025 (USD Million)
  6. Global Hospitals Market, By Region, From 2020 to 2025 (USD Million)
  7. Global Pharmaceutical Industry and CRO Market, By Region, From 2020 to 2025 (USD Million)
  8. Global Academics Market, By Region, From 2020 to 2025 (USD Million)
  9. Global Clinical Diagnostic Laboratories Market, By Region, From 2020 to 2025 (USD Million)
  10. Global Radioimmunoassay Market, By Application, From 2020 to 2025 (USD Million)
  11. Global Research Market, By Region, From 2020 to 2025 (USD Million)
  12. Global Clinical Diagnostics Market, By Region, From 2020 to 2025 (USD Million)
  13. North America Radioimmunoassay Market, By Type, From 2020 to 2025 (USD Million)
  14. North America Reagents and Kits Market, By Region, From 2020 to 2025 (USD Million)
  15. North America Analyzers Market, By Region, From 2020 to 2025 (USD Million)
  16. North America Radioimmunoassay Market, By End User, From 2020 to 2025 (USD Million)
  17. North America Hospitals Market, By Region, From 2020 to 2025 (USD Million)
  18. North America Pharmaceutical Industry and CRO Market, By Region, From 2020 to 2025 (USD Million)
  19. North America Academics Market, By Region, From 2020 to 2025 (USD Million)
  20. North America Clinical Diagnostic Laboratories Market, By Region, From 2020 to 2025 (USD Million)
  21. North America Radioimmunoassay Market, By Application, From 2020 to 2025 (USD Million)
  22. North America Research Market, By Region, From 2020 to 2025 (USD Million)
  23. North America Clinical Diagnostics Market, By Region, From 2020 to 2025 (USD Million)
  24. United States Radioimmunoassay Market, By Type, From 2020 to 2025 (USD Million)
  25. United States Radioimmunoassay Market, By End User, From 2020 to 2025 (USD Million)
  26. United States Radioimmunoassay Market, By Application, From 2020 to 2025 (USD Million)
  27. Canada Radioimmunoassay Market, By Type, From 2020 to 2025 (USD Million)
  28. Canada Radioimmunoassay Market, By End User, From 2020 to 2025 (USD Million)
  29. Canada Radioimmunoassay Market, By Application, From 2020 to 2025 (USD Million)
  30. Europe Radioimmunoassay Market, By Type, From 2020 to 2025 (USD Million)
  31. Europe Reagents and Kits Market, By Region, From 2020 to 2025 (USD Million)
  32. Europe Analyzers Market, By Region, From 2020 to 2025 (USD Million)
  33. Europe Radioimmunoassay Market, By End User, From 2020 to 2025 (USD Million)
  34. Europe Hospitals Market, By Region, From 2020 to 2025 (USD Million)
  35. Europe Pharmaceutical Industry and CRO Market, By Region, From 2020 to 2025 (USD Million)
  36. Europe Academics Market, By Region, From 2020 to 2025 (USD Million)
  37. Europe Clinical Diagnostic Laboratories Market, By Region, From 2020 to 2025 (USD Million)
  38. Europe Radioimmunoassay Market, By Application, From 2020 to 2025 (USD Million)
  39. Europe Research Market, By Region, From 2020 to 2025 (USD Million)
  40. Europe Clinical Diagnostics Market, By Region, From 2020 to 2025 (USD Million)
  41. U.K. Radioimmunoassay Market, By Type, From 2020 to 2025 (USD Million)
  42. U.K. Radioimmunoassay Market, By End User, From 2020 to 2025 (USD Million)
  43. U.K. Radioimmunoassay Market, By Application, From 2020 to 2025 (USD Million)
  44. Germany Radioimmunoassay Market, By Type, From 2020 to 2025 (USD Million)
  45. Germany Radioimmunoassay Market, By End User, From 2020 to 2025 (USD Million)
  46. Germany Radioimmunoassay Market, By Application, From 2020 to 2025 (USD Million)
  47. France Radioimmunoassay Market, By Type, From 2020 to 2025 (USD Million)
  48. France Radioimmunoassay Market, By End User, From 2020 to 2025 (USD Million)
  49. France Radioimmunoassay Market, By Application, From 2020 to 2025 (USD Million)
  50. Italy Radioimmunoassay Market, By Type, From 2020 to 2025 (USD Million)
  51. Italy Radioimmunoassay Market, By End User, From 2020 to 2025 (USD Million)
  52. Italy Radioimmunoassay Market, By Application, From 2020 to 2025 (USD Million)
  53. Spain Radioimmunoassay Market, By Type, From 2020 to 2025 (USD Million)
  54. Spain Radioimmunoassay Market, By End User, From 2020 to 2025 (USD Million)
  55. Spain Radioimmunoassay Market, By Application, From 2020 to 2025 (USD Million)
  56. Asia Pacific Radioimmunoassay Market, By Type, From 2020 to 2025 (USD Million)
  57. Asia Pacific Reagents and Kits Market, By Region, From 2020 to 2025 (USD Million)
  58. Asia Pacific Analyzers Market, By Region, From 2020 to 2025 (USD Million)
  59. Asia Pacific Radioimmunoassay Market, By End User, From 2020 to 2025 (USD Million)
  60. Asia Pacific Hospitals Market, By Region, From 2020 to 2025 (USD Million)
  61. Asia Pacific Pharmaceutical Industry and CRO Market, By Region, From 2020 to 2025 (USD Million)
  62. Asia Pacific Academics Market, By Region, From 2020 to 2025 (USD Million)
  63. Asia Pacific Clinical Diagnostic Laboratories Market, By Region, From 2020 to 2025 (USD Million)
  64. Asia Pacific Radioimmunoassay Market, By Application, From 2020 to 2025 (USD Million)
  65. Asia Pacific Research Market, By Region, From 2020 to 2025 (USD Million)
  66. Asia Pacific Clinical Diagnostics Market, By Region, From 2020 to 2025 (USD Million)
  67. Japan Radioimmunoassay Market, By Type, From 2020 to 2025 (USD Million)
  68. Japan Radioimmunoassay Market, By End User, From 2020 to 2025 (USD Million)
  69. Japan Radioimmunoassay Market, By Application, From 2020 to 2025 (USD Million)
  70. China Radioimmunoassay Market, By Type, From 2020 to 2025 (USD Million)
  71. China Radioimmunoassay Market, By End User, From 2020 to 2025 (USD Million)
  72. China Radioimmunoassay Market, By Application, From 2020 to 2025 (USD Million)
  73. India Radioimmunoassay Market, By Type, From 2020 to 2025 (USD Million)
  74. India Radioimmunoassay Market, By End User, From 2020 to 2025 (USD Million)
  75. India Radioimmunoassay Market, By Application, From 2020 to 2025 (USD Million)
  76. Australia Radioimmunoassay Market, By Type, From 2020 to 2025 (USD Million)
  77. Australia Radioimmunoassay Market, By End User, From 2020 to 2025 (USD Million)
  78. Australia Radioimmunoassay Market, By Application, From 2020 to 2025 (USD Million)
  79. South Korea Radioimmunoassay Market, By Type, From 2020 to 2025 (USD Million)
  80. South Korea Radioimmunoassay Market, By End User, From 2020 to 2025 (USD Million)
  81. South Korea Radioimmunoassay Market, By Application, From 2020 to 2025 (USD Million)
  82. Latin America Radioimmunoassay Market, By Type, From 2020 to 2025 (USD Million)
  83. Latin America Reagents and Kits Market, By Region, From 2020 to 2025 (USD Million)
  84. Latin America Analyzers Market, By Region, From 2020 to 2025 (USD Million)
  85. Latin America Radioimmunoassay Market, By End User, From 2020 to 2025 (USD Million)
  86. Latin America Hospitals Market, By Region, From 2020 to 2025 (USD Million)
  87. Latin America Pharmaceutical Industry and CRO Market, By Region, From 2020 to 2025 (USD Million)
  88. Latin America Academics Market, By Region, From 2020 to 2025 (USD Million)
  89. Latin America Clinical Diagnostic Laboratories Market, By Region, From 2020 to 2025 (USD Million)
  90. Latin America Radioimmunoassay Market, By Application, From 2020 to 2025 (USD Million)
  91. Latin America Research Market, By Region, From 2020 to 2025 (USD Million)
  92. Latin America Clinical Diagnostics Market, By Region, From 2020 to 2025 (USD Million)
  93. Brazil Radioimmunoassay Market, By Type, From 2020 to 2025 (USD Million)
  94. Brazil Radioimmunoassay Market, By End User, From 2020 to 2025 (USD Million)
  95. Brazil Radioimmunoassay Market, By Application, From 2020 to 2025 (USD Million)
  96. Argentina Radioimmunoassay Market, By Type, From 2020 to 2025 (USD Million)
  97. Argentina Radioimmunoassay Market, By End User, From 2020 to 2025 (USD Million)
  98. Argentina Radioimmunoassay Market, By Application, From 2020 to 2025 (USD Million)
  99. Mexico Radioimmunoassay Market, By Type, From 2020 to 2025 (USD Million)
  100. Mexico Radioimmunoassay Market, By End User, From 2020 to 2025 (USD Million)
  101. Mexico Radioimmunoassay Market, By Application, From 2020 to 2025 (USD Million)
  102. Rest of Latin America Radioimmunoassay Market, By Type, From 2020 to 2025 (USD Million)
  103. Rest of Latin America Radioimmunoassay Market, By End User, From 2020 to 2025 (USD Million)
  104. Rest of Latin America Radioimmunoassay Market, By Application, From 2020 to 2025 (USD Million)
  105. Middle East and Africa Radioimmunoassay Market, By Type, From 2020 to 2025 (USD Million)
  106. Middle East and Africa Reagents and Kits Market, By Region, From 2020 to 2025 (USD Million)
  107. Middle East and Africa Analyzers Market, By Region, From 2020 to 2025 (USD Million)
  108. Middle East and Africa Radioimmunoassay Market, By End User, From 2020 to 2025 (USD Million)
  109. Middle East and Africa Hospitals Market, By Region, From 2020 to 2025 (USD Million)
  110. Middle East and Africa Pharmaceutical Industry and CRO Market, By Region, From 2020 to 2025 (USD Million)
  111. Middle East and Africa Academics Market, By Region, From 2020 to 2025 (USD Million)
  112. Middle East and Africa Clinical Diagnostic Laboratories Market, By Region, From 2020 to 2025 (USD Million)
  113. Middle East and Africa Radioimmunoassay Market, By Application, From 2020 to 2025 (USD Million)
  114. Middle East and Africa Research Market, By Region, From 2020 to 2025 (USD Million)
  115. Middle East and Africa Clinical Diagnostics Market, By Region, From 2020 to 2025 (USD Million)
  116. Middle East Radioimmunoassay Market, By Type, From 2020 to 2025 (USD Million)
  117. Middle East Radioimmunoassay Market, By End User, From 2020 to 2025 (USD Million)
  118. Middle East Radioimmunoassay Market, By Application, From 2020 to 2025 (USD Million)
  119. Africa Radioimmunoassay Market, By Type, From 2020 to 2025 (USD Million)
  120. Africa Radioimmunoassay Market, By End User, From 2020 to 2025 (USD Million)
  121. Africa Radioimmunoassay Market, By Application, From 2020 to 2025 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample